The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
Related Posts
Sacklers Up Their Offer to Settle Purdue Opioids Cases, With a New Condition
- staff
- January 23, 2025
- 1 min
- 0
A group of 15 states have reached a tentative new deal that would require them…
2025 Oscar Nominations: ‘Emilia Pérez’ and ‘The Brutalist’ Get Multiple Nods
- staff
- January 23, 2025
- 1 min
- 0
The two films secured nominations in most of the major categories, including best picture, a…
Korea Zinc Shareholder Meeting Takes a Dramatic Turn
- staff
- January 23, 2025
- 1 min
- 0
An eventful shareholder meeting provided the latest twist in the dispute between the families whose…